These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19463510)

  • 21. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
    Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early reduction of QT dispersion after primary percutaneous intervention in ST-segment elevation acute myocardial infarction. Mechanisms and clinical implications.
    Jiménez-Candil J; Hernández Hernández J; Aguero VL; Martín A; Martín F; Moríñigo JL; Martín-Luengo C
    Cardiology; 2009; 113(3):172-9. PubMed ID: 19136825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction: a novel predictor of prognosis after acute myocardial infarction.
    Wakabayashi K; Suzuki H; Honda Y; Wakatsuki D; Kawachi K; Ota K; Koba S; Shimizu N; Asano F; Sato T; Takeyama Y
    J Am Coll Cardiol; 2008 Aug; 52(7):518-22. PubMed ID: 18687243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW;
    Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies.
    Huynh T; Perron S; O'Loughlin J; Joseph L; Labrecque M; Tu JV; Théroux P
    Circulation; 2009 Jun; 119(24):3101-9. PubMed ID: 19506117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
    Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
    Wiederkehr D; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Corbelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2327-34. PubMed ID: 19635046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.
    Bonnefoy E; Steg PG; Boutitie F; Dubien PY; Lapostolle F; Roncalli J; Dissait F; Vanzetto G; Leizorowicz A; Kirkorian G; ; Mercier C; McFadden EP; Touboul P
    Eur Heart J; 2009 Jul; 30(13):1598-606. PubMed ID: 19429632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention.
    Garcia-Alvarez A; Arzamendi D; Loma-Osorio P; Kiamco R; Masotti M; Sionis A; Betriu A; Brugada J; Bosch X
    Am J Cardiol; 2009 Apr; 103(8):1073-7. PubMed ID: 19361592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An active lifestyle improves outcome of primary angioplasty in elderly patients with acute myocardial infarction.
    Rengo G; Galasso G; Piscione F; Golino L; Fortunato F; Zincarelli C; Cassese S; Abete P; Chiariello M; Rengo F; Leosco D
    Am Heart J; 2007 Aug; 154(2):352-60. PubMed ID: 17643588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis).
    Gibson CM; Pride YB; Buros JL; Ciaglo LN; Morrow DA; Scirica BM; Stone PH;
    Am J Cardiol; 2009 Jul; 104(1):36-40. PubMed ID: 19576318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of ambulance use on early reperfusion therapies for acute myocardial infarction.
    Song L; Hu DY; Yan HB; Yang JG; Sun YH; Li C; Liu SS; Wu D; Feng Q
    Chin Med J (Engl); 2008 May; 121(9):771-5. PubMed ID: 18701037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction.
    Hasin T; Sorkin A; Markiewicz W; Hammerman H; Aronson D
    Am J Cardiol; 2009 Aug; 104(4):486-91. PubMed ID: 19660599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty.
    Eitel I; Desch S; Sareban M; Fuernau G; Gutberlet M; Schuler G; Thiele H
    Am Heart J; 2009 Nov; 158(5):806-13. PubMed ID: 19853702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distortion of the QRS in elderly patients with myocardial infarction.
    García-Rubira JC; Núnez-Gil I; García-Borbolla R; Lennie V; Manzano MC; Cobos MA; de Isla LP; Fernández-Ortiz A; Macaya C
    Cardiol J; 2009; 16(5):418-25. PubMed ID: 19753520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.